- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02926560
Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism
January 11, 2019 updated by: Centre Hospitalier Universitaire de Nīmes
The aim of this study is
1) To describe the level and determinants of methotrexate adherence in patients with chronic inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) in the department of rheumatology in the Nîmes University Hospital
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
137
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gard
-
Nîmes, Gard, France, 30000
- Chu Nimes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients with chronic inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) treated by methotrexate in the department of rheumatology in the Nîmes University Hospital
Description
Inclusion Criteria:
- treated by methotrexate
- patients with chronic inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis)
Exclusion Criteria:
- methotrexate for other diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Medication Adherence Measure= Morisky scale
Time Frame: day 0
|
day 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Cécile Gaujoux-Viala, MD,PhD, Chu Nimes
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
May 30, 2018
Study Completion (Actual)
May 30, 2018
Study Registration Dates
First Submitted
September 16, 2016
First Submitted That Met QC Criteria
October 5, 2016
First Posted (Estimate)
October 6, 2016
Study Record Updates
Last Update Posted (Actual)
January 14, 2019
Last Update Submitted That Met QC Criteria
January 11, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Local/2015/CGV-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatic Diseases
-
Xijing HospitalAir Force Military Medical University, ChinaUnknownRheumatic Valve DiseaseChina
-
Assiut UniversityNot yet recruitingRheumatic Mitral Valve Disease
-
Paris Cardiovascular Research Center (Inserm U970)Not yet recruitingRheumatic Heart Disease in Children
-
Duke UniversityChildhood Arthritis and Rheumatology Research AllianceRecruitingRheumatic Joint DiseaseUnited States, Canada, Israel, Italy, Puerto Rico
-
Children's National Research InstituteUniversity of Cape Town; Thrasher Research Fund; Murdoch Childrens Research Institute and other collaboratorsUnknownHeart Diseases | Rheumatic Heart Disease | Rheumatic Heart Disease in Children | Latent Rheumatic Heart DiseaseUganda
-
Assiut UniversityRecruitingFollow up of Moderate Aortic Regurge After Rheumatic Mitral Valve ReplacementEgypt
-
Centre Hospitalier Universitaire de NiceCompleted
-
Ettore Sansavini Health Science FoundationUnknownTricuspid (Valve) Insufficiency (Rheumatic)Italy
-
University Hospital Inselspital, BerneInstituto de Cardiología Paredes-Horna, Arequipa; Hospital Nacional Carlos...CompletedRheumatic Heart Disease | Acute Rheumatic FeverPeru, Switzerland
-
University Hospital Inselspital, BerneRecruitingRheumatic Heart Disease | Rheumatic Heart Disease in ChildrenNepal